CT
EW icon

Columbia Trust’s Edwards Lifesciences EW Stock Holding History

Columbia Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.61M Buy
21,125
+4,380
+26% +$305K 0.73% 43
2023
Q3 		$1.16M Buy
16,745
+132
+0.8% +$10.6K 0.67% 48
2023
Q2 		$1.57M Buy
16,613
+845
+5% +$73.4K 0.88% 36
2023
Q1 		$1.3M Buy
15,768
+868
+6% +$68.2K 0.75% 40
2022
Q4 		$1.11M Sell
14,900
-2,722
-15% -$210K 0.62% 46
2022
Q3 		$1.46M Sell
17,622
-168
-0.9% -$16.2K 0.82% 32
2022
Q2 		$1.69M Sell
17,790
-32
-0.2% -$3.31K 0.91% 28
2022
Q1 		$2.14M Buy
17,822
+1,214
+7% +$136K 1% 25
2021
Q4 		$1.88M Hold
16,608
– – 0.99% 23
2021
Q3 		$1.88M Buy
16,608
+480
+3% +$54.8K 0.99% 23
2021
Q2 		$1.67M Buy
16,128
+1,111
+7% +$105K 0.95% 28
2021
Q1 		$1.25M Buy
15,017
+730
+5% +$61.7K 0.78% 35
2020
Q4 		$1.3M Buy
+14,287
New +$1.19M 0.9% 33
2020
Q2 		$973K Buy
14,099
+1,307
+10% +$92.9K 0.87% 38
2020
Q1 		$803K Buy
12,792
+141
+1% +$10.2K 0.88% 35
2019
Q4 		$983K Buy
+12,651
New +$988K 0.88% 37

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Columbia Trust's EW Position: Q4 2023 in Review

Columbia Trust increased its Edwards Lifesciences (EW) stake by 26% in Q4 2023, buying an estimated $305K and bringing the position to 21,125 shares worth $1.61M. The position accounts for 0.73% of the portfolio, ranked #43.

Columbia Trust first reported a position in EW in Q4 2019 and has held it in 16 quarters since. The position peaked at $2.14M in Q1 2022. 1,244 funds tracked by Wall St. Rank hold EW as of Q4 2023.

  • Columbia Trust held 21,125 shares of Edwards Lifesciences worth $1.61M as of Q4 2023.
  • Columbia Trust bought 4,380 Edwards Lifesciences shares in Q4 2023, an estimated $305K.
  • Edwards Lifesciences made up 0.73% of Columbia Trust's portfolio in Q4 2023, its #43 holding.
  • Columbia Trust first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 16 quarters since.
  • Columbia Trust's Edwards Lifesciences position peaked at $2.14M in Q1 2022.
  • 1,244 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Columbia Trust's 13F filing for Q4 2023, filed 17 Jan 2024.